Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2010, Article ID 740968, 7 pages
http://dx.doi.org/10.1155/2010/740968
Review Article

Molecular Abnormalities in Ovarian Cancer Subtypes Other than High-Grade Serous Carcinoma

Department of Pathology, Vancouver General Hospital, University of British Columbia, Vancouver 1st Floor JPPN, 855 West 12th Ave, Vanouver, BC, Canada V5Z 1M9

Received 10 July 2009; Accepted 16 September 2009

Academic Editor: Maurie M. Markman

Copyright © 2010 C. Blake Gilks. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [38 citations]

The following is the list of published articles that have cited the current article.

  • Shun'ichiro Taniguchi, Minoru Fujimori, Takayuki Sasaki, Hiroko Tsutsui, Yuko Shimatani, Keiichi Seki, and Jun Amano, “Targeting solid tumors with non-pathogenic obligate anaerobic bacteria,” Cancer Science, vol. 101, no. 9, pp. 1925–1932, 2010. View at Publisher · View at Google Scholar
  • E. Leblanc, F. Narducci, I. Farre, and P. Vennin, “The new insights of ovarian carcinogenesis ... and their possible impacts on our current practice,” Gynecologie Obstetrique & Fertilite, vol. 38, no. 11, pp. 645–647, 2010. View at Publisher · View at Google Scholar
  • Kimberly C Wiegand, Steve E Kalloger, Winnie Yang, Alireza Heravi-Moussavi, Ryan Giuliany, Christine Chow, John Fee, Abdalnasser Zayed, Leah Prentice, Nataliya Melnyk, Gulisa Turashvili, Sohrab P Shah, Allen D Delaney, Jason Madore, Stephen Yip, Andrew W McPherson, Gavin Ha, Lynda Bell, Sian Fereday, Angela Tam, Laura Galletta, Patricia N Tonin, Osama M Al-Agha, Diane Provencher, Dianne Miller, Steven J M Jones, Richard A Moore, Gregg B Morin, Arusha Oloumi, Niki Boyd, Samuel A Aparicio, Ie-Ming Shih, Anne-Marie Mes-Masson, Yongjun Zhao, David D Bowtell, Martin Hirst, Blake Gilks, Marco A Marra, David G Huntsman, Kane Tse, Thomas Zeng, Janine Senz, Melissa K McConechy, and Michael S Anglesio, “ARID1A mutations in endometriosis-associated ovarian carcinomas.,” The New England journal of medicine, vol. 363, no. 16, pp. 1532–43, 2010. View at Publisher · View at Google Scholar
  • Elisabetta Kuhn, Alan K. Meeker, Kala Visvanathan, Amy L. Gross, Tian-Li Wang, Robert J. Kurman, and Ie-Ming Shih, “Telomere length in different histologic types of ovarian carcinoma with emphasis on clear cell carcinoma,” Modern Pathology, vol. 24, no. 8, pp. 1139–1145, 2011. View at Publisher · View at Google Scholar
  • A. Staebler, “Vorläuferläsionen der Ovarialkarzinome,” Der Pathologe, vol. 32, no. S2, pp. 265–270, 2011. View at Publisher · View at Google Scholar
  • Shelby M. King, and Joanna E. Burdette, “Evaluating the progenitor cells of ovarian cancer: analysis of current animal models,” Bmb Reports, vol. 44, no. 7, pp. 435–445, 2011. View at Publisher · View at Google Scholar
  • Shelby M King, and Joanna E Burdette, “Evaluating the progenitor cells of ovarian cancer: analysis of current animal models.,” BMB reports, vol. 44, no. 7, pp. 435–45, 2011. View at Publisher · View at Google Scholar
  • Shoji Haruta, Naoto Furukawa, Yoriko Yoshizawa, Taihei Tsunemi, Akira Nagai, Ryuji Kawaguchi, Yasuhito Tanase, Shozo Yoshida, and Hiroshi Kobayashi, “Molecular genetics and epidemiology of epithelial ovarian cancer (Review),” Oncology Reports, vol. 26, no. 6, pp. 1347–1356, 2011. View at Publisher · View at Google Scholar
  • Colin J.R. Stewart, Yee Leung, Michael D. Walsh, Rhiannon J. Walters, Joanne P. Young, and Daniel D. Buchanan, “KRAS mutations in ovarian low-grade endometrioid adenocarcinoma: association with concurrent endometriosis,” Human Pathology, vol. 43, no. 8, pp. 1177–1183, 2012. View at Publisher · View at Google Scholar
  • Kasmintan A. Schrader, Jane Hurlburt, Steve E. Kalloger, Samantha Hansford, Sean Young, David G. Huntsman, C. Blake Gilks, and Jessica N. McAlpine, “Germline BRCA1 and BRCA2 Mutations in Ovarian Cancer,” Obstetrics & Gynecology, vol. 120, no. 2,Part1, pp. 235–240, 2012. View at Publisher · View at Google Scholar
  • Livia Quattrocchi, Melanie Sisson, Andrew Green, Stewart G. Martin, Lindy Durrant, and Suha Deen, “Expression of angiogenic chemokines in ovarian clear cell carcinoma,” Journal of Obstetrics and Gynaecology Research, vol. 39, no. 1, pp. 297–304, 2012. View at Publisher · View at Google Scholar
  • Celeste Leigh Pearce, Claire Templeman, Mary Anne Rossing, Alice Lee, Aimee M Near, Penelope M Webb, Christina M Nagle, Jennifer A Doherty, Kara L Cushing-Haugen, Kristine G Wicklund, Jenny Chang-Claude, Rebecca Hein, Galina Lurie, Lynne R Wilkens, Michael E Carney, Marc T Goodman, Kirsten Moysich, Susanne K Kjaer, Estrid Hogdall, Allan Jensen, Ellen L Goode, Brooke L Fridley, Melissa C Larson, Joellen M Schildkraut, Rachel T Palmieri, Daniel W Cramer, Kathryn L Terry, Allison F Vitonis, Linda J Titus, Argyrios Ziogas, Wendy Brewster, Hoda Anton-Culver, Alexandra Gentry-Maharaj, Susan J Ramus, A Rebecca Anderson, Doerthe Brueggmann, Peter A Fasching, Simon A Gayther, David G Huntsman, Usha Menon, Roberta B Ness, Malcolm C Pike, Harvey Risch, Anna H Wu, and Andrew Berchuck, “Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies,” The Lancet Oncology, vol. 13, no. 4, pp. 385–394, 2012. View at Publisher · View at Google Scholar
  • Ananta Gurung, Tawny Hung, Jason Morin, and C Blake Gilks, “Molecular abnormalities in ovarian carcinoma: clinical, morphological and therapeutic correlates,” Histopathology, vol. 62, no. 1, pp. 59–70, 2012. View at Publisher · View at Google Scholar
  • Satoe Fujiwara, Masanori Kanemura, Akiko Tanabe, Yoshiki Yamashita, Masahide Ohmichi, Yoshito Terai, Hiroshi Kawaguchi, Masaaki Takai, Saha Yoo, Yoshimichi Tanaka, Tomohito Tanaka, Satoshi Tsunetoh, and Hiroshi Sasaki, “GPR30 regulates the EGFR-Akt cascade and predicts lower survival in patients with ovarian cancer.,” Journal of ovarian research, vol. 5, no. 1, pp. 35, 2012. View at Publisher · View at Google Scholar
  • Hui Shen, Brooke L. Fridley, Honglin Song, Kate Lawrenson, Julie M. Cunningham, Susan J. Ramus, Mine S. Cicek, Jonathan Tyrer, Douglas Stram, Melissa C. Larson, Martin Köbel, Argyrios Ziogas, Wei Zheng, Hannah P. Yang, Anna H. Wu, Eva L. Wozniak, Yin Ling Woo, Boris Winterhoff, Elisabeth Wik, Alice S. Whittemore, Nicolas Wentzensen, Rachel Palmieri Weber, Allison F. Vitonis, Daniel Vincent, Robert A. Vierkant, Ignace Vergote, David Van Den Berg, Anne M. Van Altena, Shelley S. Tworoger, Pamela J. Thompson, Daniel C. Tessier, Kathryn L. Terry, Soo-Hwang Teo, Claire Templeman, Daniel O. Stram, Melissa C. Southey, Weiva Sieh, Nadeem Siddiqui, Yurii B. Shvetsov, Xiao-Ou Shu, Viji Shridhar, Shan Wang-Gohrke, Gianluca Severi, Ira Schwaab, Helga B. Salvesen, Iwona K. Rzepecka, Ingo B. Runnebaum, Mary Anne Rossing, Lorna Rodriguez-Rodriguez, Harvey A. Risch, Stefan P. Renner, Elizabeth M. Poole, Malcolm C. Pike, Catherine M. Phelan, Liisa M. Pelttari, Tanja Pejovic, James Paul, Irene Orlow, Siti Zawiah Omar, Sara H. Olson, Kunle Odunsi, Stefan Nickels, Heli Nevanlinna, Roberta B. Ness, Steven A. Narod, Toru Nakanishi, Kirsten B. Moysich, Alvaro N.A. Monteiro, Joanna Moes-Sosnowska, Francesmary Modugno, Usha Menon, John R. McLaughlin, Valerie McGuire, Keitaro Matsuo, Noor Azmi Mat Adenan, Leon F.A.G Massuger, Galina Lurie, Lene Lundvall, Jan Lubinski, Jolanta Lissowska, Douglas A. Levine, Arto Leminen, Alice W. Lee, Nhu D. Le, Sandrina Lambrechts, Diether Lambrechts, Jolanta Kupryjanczyk, Camilla Krakstad, Gottfried E. Konecny, Susanne Krüger Kjaer, Lambertus A. Kiemeney, Linda E. Kelemen, Gary L. Keeney, Beth Y. Karlan, Rod Karevan, Kimberly R. Kalli, Hiroaki Kajiyama, Bu-Tian Ji, Allan Jensen, Anna Jakubowska, Edwin Iversen, Satoyo Hosono, Claus K. Høgdall, Estrid Høgdall, Maureen Hoatlin, Peter Hillemanns, Florian Heitz, Rebecca Hein, Philipp Harter, Mari K. Halle, Per Hall, Jacek Gronwald, Martin Gore, Marc T. Goodman, Graham G. Giles, Aleksandra Gentry-Maharaj, Montserrat Garcia-Closas, James M. Flanagan, Peter A. Fasching, Arif B. Ekici, Robert Edwards, Diana Eccles, Douglas F. Easton, Matthias Dürst, Andreas du Bois, Thilo Dörk, Jennifer A. Doherty, Evelyn Despierre, Agnieszka Dansonka-Mieszkowska, Cezary Cybulski, Daniel W. Cramer, Linda S. Cook, Xiaoqing Chen, Bridget Charbonneau, Jenny Chang-Claude, Ian Campbell, Ralf Butzow, Clareann H. Bunker, Doerthe Brueggmann, Robert Brown, Angela Brooks-Wilson, Louise A. Brinton, Natalia Bogdanova, Matthew S. Block, Elizabeth Benjamin, Jonathan Beesley, Matthias W. Beckmann, Elisa V. Bandera, Laura Baglietto, François Bacot, Sebastian M. Armasu, Natalia Antonenkova, Hoda Anton-Culver, Katja K. Aben, Dong Liang, Xifeng Wu, Karen Lu, Michelle A.T. Hildebrandt, Joellen M. Schildkraut, Thomas A. Sellers, David Huntsman, Andrew Berchuck, Georgia Chenevix-Trench, Simon A. Gayther, Paul D.P. Pharoah, Peter W. Laird, Ellen L. Goode, and Celeste Leigh Pearce, “Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer,” Nature Communications, vol. 4, pp. 1628, 2013. View at Publisher · View at Google Scholar
  • Madalene A. Earp, Linda E. Kelemen, Anthony M. Magliocco, Kenneth D. Swenerton, Georgia Chenevix-Trench, Yi Lu, Alexander Hein, Arif B. Ekici, Matthias W. Beckmann, Peter A. Fasching, Diether Lambrechts, Evelyn Despierre, Ignace Vergote, Sandrina Lambrechts, Jennifer A. Doherty, Mary Anne Rossing, Jenny Chang-Claude, Anja Rudolph, Grace Friel, Kirsten B. Moysich, Kunle Odunsi, Lara Sucheston-Campbell, Galina Lurie, Marc T. Goodman, Michael E. Carney, Pamela J. Thompson, Ingo B. Runnebaum, Matthias Dürst, Peter Hillemanns, Thilo Dörk, Natalia Antonenkova, Natalia Bogdanova, Arto Leminen, Heli Nevanlinna, Liisa M. Pelttari, Ralf Butzow, Clareann H. Bunker, Francesmary Modugno, Robert P. Edwards, Roberta B. Ness, Andreas Bois, Florian Heitz, Ira Schwaab, Philipp Harter, Beth Y. Karlan, Christine Walsh, Jenny Lester, Allan Jensen, Susanne K. Kjær, Claus K. Høgdall, Estrid Høgdall, Lene Lundvall, Thomas A. Sellers, Brooke L. Fridley, Ellen L. Goode, Julie M. Cunningham, Robert A. Vierkant, Graham G. Giles, Laura Baglietto, Gianluca Severi, Melissa C. Southey, Dong Liang, Xifeng Wu, Karen Lu, Michelle A. T. Hildebrandt, Douglas A. Levine, Maria Bisogna, Joellen M. Schildkraut, Edwin S. Iversen, Rachel Palmieri Weber, Andrew Berchuck, Daniel W. Cramer, Kathryn L. Terry, Elizabeth M. Poole, Shelley S. Tworoger, Elisa V. Bandera, Urmila Chandran, Irene Orlow, Sara H. Olson, Elisabeth Wik, Helga B. Salvesen, Line Bjorge, Mari K. Halle, Anne M. Altena, Katja K. H. Aben, Lambertus A. Kiemeney, Leon F. A. G. Massuger, Tanja Pejovic, Yukie T. Bean, Cezary Cybulski, Jacek Gronwald, Jan Lubinski, Nicolas Wentzensen, Louise A. Brinton, Jolanta Lissowska, Montserrat Garcia-Closas, Ed Dicks, Joe Dennis, Douglas F. Easton, Honglin Song, Jonathan P. Tyrer, Paul D. P. Pharoah, Diana Eccles, Ian G. Campbell, Alice S. Whittemore, Valerie McGuire, Weiva Sieh, Joseph H. Rothstein, James M. Flanagan, James Paul, Robert Brown, Catherine M. Phelan, Harvey A. Risch, John R. McLaughlin, Steven A. Narod, Argyrios Ziogas, Hoda Anton-Culver, Aleksandra Gentry-Maharaj, Usha Menon, Simon A. Gayther, Susan J. Ramus, Anna H. Wu, Celeste L. Pearce, Malcolm C. Pike, Agnieszka Dansonka-Mieszkowska, Iwona K. Rzepecka, Lukasz M. Szafron, Jolanta Kupryjanczyk, Linda S. Cook, Nhu D. Le, and Angela Brooks-Wilson, “Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA,” Human Genetics, 2013. View at Publisher · View at Google Scholar
  • Colin J. R. Stewart, Michael D. Walsh, Charley A. Budgeon, Maxine L. Crook, and Daniel B. Buchanan, “Immunophenotypic analysis of ovarian endometrioid adenocarcinoma: correlation with KRAS mutation and the presence of endometriosis,” Pathology, vol. 45, no. 6, pp. 559–566, 2013. View at Publisher · View at Google Scholar
  • Kara Cushing-Haugen, Andrew Berchuck, Joellen Schildkraut, Yurii B. Shvetsov, Rachel Palmieri Weber, Lucy Akushevich, Roberta B. Ness, Stalo Karageorgi, Penelope M. Webb, Harvey Risch, Marc T. Goodman, Galina Lurie, Michael E. Carney, Kathryn L. Terry, Christina M. Nagle, Malcolm Pike, Mary Anne Rossing, Melissa A. Merritt, Pamela J. Thompson, Wei-Hsuan Lo-Ciganic, Weiva Sieh, Kirsten Moysich, Jennifer A. Doherty, and Celeste L. Pearce, “Genital Powder Use and Risk of Ovarian Cancer: A Pooled Analysis of 8,525 Cases and 9,859 Controls,” Cancer Prevention Research, vol. 6, no. 8, pp. 811–821, 2013. View at Publisher · View at Google Scholar
  • Vijaya Galic, Robert L. Coleman, and Thomas J. Herzog, “Unmet Needs in Ovarian Cancer: Dividing Histologic Subtypes to Exploit Novel Targets and Pathways,” Current Cancer Drug Targets, vol. 13, no. 6, pp. 698–707, 2013. View at Publisher · View at Google Scholar
  • Hsien-Neng Huang, Wen-Chih Huang, Ching-Hung Lin, Ying-Cheng Chiang, Hsin-Ying Huang, and Kuan-Ting Kuo, “Chromosome 20q13.2 ZNF217 locus amplification correlates with decreased E-cadherin expression in ovarian clear cell carcinoma with PI3K-Akt pathway alterations,” Human Pathology, 2014. View at Publisher · View at Google Scholar
  • Angiolo Gadducci, Nora Lanfredini, and Roberta Tana, “Novel insights on the malignant transformation of endometriosis into ovarian carcinoma,” Gynecological Endocrinology, pp. 1–6, 2014. View at Publisher · View at Google Scholar
  • Britton Trabert, Roberta B. Ness, Wei-Hsuan Lo-Ciganic, Megan A. Murphy, Ellen L. Goode, Elizabeth M. Poole, Louise A. Brinton, Penelope M. Webb, Christina M. Nagle, Susan J. Jordan, Harvey A. Risch, Mary Anne Rossing, Jennifer A. Doherty, Marc T. Goodman, Galina Lurie, Susanne K. Kjaer, Estrid Hogdall, Allan Jensen, Daniel W. Cramer, Kathryn L. Terry, Allison Vitonis, Elisa V. Bandera, Sara Olson, Melony G. King, Urmila Chandran, Hoda Anton-Culver, Argyrios Ziogas, Usha Menon, Simon A. Gayther, Susan J. Ramus, Aleksandra Gentry-Maharaj, Anna H. Wu, Celeste Leigh Pearce, Malcolm C. Pike, Andrew Berchuck, Joellen M. Schildkraut, and Nicolas Wentzensen, “Aspirin, Nonaspirin Nonsteroidal Anti-inflammatory Drug, and Acetaminophen Use and Risk of Invasive Epithelial Ovarian Cancer: A Pooled Analysis in the Ovarian Cancer Association Consortium,” Jnci-Journal of The National Cancer Institute, vol. 106, no. 2, 2014. View at Publisher · View at Google Scholar
  • Dimple A. Modi, Suhair Sunoqrot, Jason Bugno, Daniel D. Lantvit, Seungpyo Hong, and Joanna E. Burdette, “Targeting of follicle stimulating hormone peptide-conjugated dendrimers to ovarian cancer cells,” Nanoscale, vol. 6, no. 5, pp. 2812, 2014. View at Publisher · View at Google Scholar
  • B. Yang, D. Wang, H. Chen, and F. Yang, “The association between endometriosis and survival outcomes of ovarian cancer: Evidence-based on a meta-analysis,” Nigerian Journal Of Clinical Practice, vol. 18, no. 5, pp. 577–583, 2015. View at Publisher · View at Google Scholar
  • Gillian E. Hanley, Jessica N. McAlpine, Janice S. Kwon, and Gillian Mitchell, “Opportunistic salpingectomy for ovarian cancer prevention,” Gynecologic Oncology Research and Practice, vol. 2, no. 1, 2015. View at Publisher · View at Google Scholar
  • Erin K. Crane, Suet-Yan Kwan, Daisy I. Izaguirre, Yvonne T. M. Tsang, Lisa K. Mullany, Zhifei Zu, JoAnne S. Richards, David M. Gershenson, and Kwong-Kwok Wong, “Nutlin-3 alpha: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas,” Plos One, vol. 10, no. 8, 2015. View at Publisher · View at Google Scholar
  • Joan L. Walker, C. Bethan Powell, Lee-may Chen, Jeanne Carter, Victoria L. Bae Jump, Lynn P. Parker, Mark E. Borowsky, and Randall K. Gibb, “Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer,” Cancer, vol. 121, no. 13, pp. 2108–2120, 2015. View at Publisher · View at Google Scholar
  • W Glenn McCluggage, Meagan J Judge, Blaise A Clarke, Ben Davidson, C Blake Gilks, Harry Hollema, Jonathan A Ledermann, Xavier Matias-Guiu, Yoshiki Mikami, Colin JR Stewart, Russell Vang, and Lynn Hirschowitz, “Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR),” Modern Pathology, 2015. View at Publisher · View at Google Scholar
  • Farzad Jamshidi, Torsten O. Nielsen, and David G. Huntsman, “Cancer genomics: why rare is valuable,” Journal of Molecular Medicine, 2015. View at Publisher · View at Google Scholar
  • Olga Kondrashova, Clare J. Love, Sebastian Lunke, Arthur L. Hsu, Paul M. Waring, and Graham R. Taylor, “High-Throughput Amplicon-Based Copy Number Detection of 11 Genes in Formalin-Fixed Paraffin-Embedded Ovarian Tumour Samples by MLPA-Seq,” Plos One, vol. 10, no. 11, 2015. View at Publisher · View at Google Scholar
  • Pedro Acien, Irene Velasco, Maribel Acien, Cecilia Capello, and Pilar Vela, “Epithelial Ovarian Cancers and Endometriosis,” Gynecologic And Obstetric Investigation, vol. 79, no. 2, pp. 126–135, 2015. View at Publisher · View at Google Scholar
  • Stefan P. Renner, Pamela L. Strissel, Matthias W. Beckmann, Johannes Lermann, Stefanie Burghaus, Janina Hackl, Peter A. Fasching, and Reiner Strick, “Inhibition of Adhesion, Proliferation, and Invasion of Primary Endometriosis and Endometrial Stromal and Ovarian Carcinoma Cells by a Nonhyaluronan Adhesion Barrier Gel,” BioMed Research International, vol. 2015, pp. 1–10, 2015. View at Publisher · View at Google Scholar
  • Akira Yokoi, Yusuke Yoshioka, Yusuke Yamamoto, Mitsuya Ishikawa, Shun-ichi Ikeda, Tomoyasu Kato, Tohru Kiyono, Fumitaka Takeshita, Hiroaki Kajiyama, Fumitaka Kikkawa, and Takahiro Ochiya, “Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer,” Nature Communications, vol. 8, pp. 14470, 2017. View at Publisher · View at Google Scholar
  • Michael S. Anglesio, and Paul J. Yong, “Endometriosis-associated Ovarian Cancers,” Clinical Obstetrics and Gynecology, vol. 60, no. 4, pp. 711–727, 2017. View at Publisher · View at Google Scholar
  • Dörthe Brüggmann, Katharina Pulch, Doris Klingelhöfer, Celeste Leigh Pearce, and David A. Groneberg, “Ovarian cancer: density equalizing mapping of the global research architecture,” International Journal of Health Geographics, vol. 16, no. 1, 2017. View at Publisher · View at Google Scholar
  • Engin Oral, Ovgu Aydin, Banu Aygun Kumbak, Sennur İlvan, Handan Yilmaz, Esra Tustas, Tugan Bese, Fuat Demirkiran, and Macit Arvas, “Concomitant endometriosis in malignant and borderline ovarian tumours,” Journal of Obstetrics and Gynaecology, pp. 1–6, 2018. View at Publisher · View at Google Scholar
  • Wera Berge, Kenneth Mundt, Hung Luu, and Paolo Boffetta, “Genital use of talc and risk of ovarian cancer,” European Journal of Cancer Prevention, vol. 27, no. 3, pp. 248–257, 2018. View at Publisher · View at Google Scholar
  • Gillian E. Hanley, Jessica N. McAlpine, Dianne Miller, David Huntsman, Kasmintan A. Schrader, C. Blake Gilks, and Gillian Mitchell, “A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer prevention,” BMC Cancer, vol. 18, no. 1, 2018. View at Publisher · View at Google Scholar